The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationProphylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantationImprovements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysisAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.Lowering the prophylactic platelet transfusion threshold: a prospective analysis.A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.The practice of platelet transfusion in the intensive care unit.Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.Platelet transfusions for patients with haematological malignancies: who needs them?The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocolFunctional recovery of stored platelets after transfusion.Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic reviewRationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyPlatelet transfusionsRevisitation of the clinical indications for the transfusion of platelet concentrates.Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.Guidelines for the transfusion of platelets.Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.The current state of platelet and granulocyte cryopreservation.
P2860
Q24186359-A639A4E3-A3E0-4291-8F16-8465E87E5609Q24186913-BA5DE8F5-7E40-46F2-A328-6E28818EAF92Q24187751-591008ED-D5E3-40EE-ABD6-490A67EA1DFBQ24197779-9861B973-E571-4DA2-BB82-0D19F377DFF3Q24198288-D8EA638A-6C87-469F-BB80-32DFAC7E56A7Q24198774-FC9B000C-3EA0-45FB-A18D-11D278554216Q24198795-1358189C-7C56-4963-83B5-C0ACDD4779B8Q24198832-BFD5FA1B-EEE5-4880-993D-5A6A7C0EA333Q24245960-82B68DCA-04D6-4D07-A36E-7A1DC3CF6680Q27336142-4C108E12-BF97-4C86-9819-6391648698B4Q30248355-BD770325-CDF3-4F13-B44B-57C18CA6DCA0Q30525402-7822D614-C338-4BC1-B664-3C31194E8697Q33337229-91BBE175-DA33-4E01-9F73-98BDC5CC432BQ33369834-64060D55-ADF4-4320-9FE1-1BA30C21CDEEQ33375078-A67AB33F-53BA-4F3C-9D50-462BEFC138F2Q33395035-86DCBE98-4A8C-43B5-85F3-523A01FBBF81Q33395509-D7A1D808-D477-4A33-BC0D-73D50FB7FBD9Q33403659-4FFA3C1A-4A2B-46AA-8170-A97ADBD8D688Q33413225-ABBE1BB9-C553-4AFC-8A1F-4FC570A52524Q33430451-74F1A1CD-D527-4020-8C73-28AFEFA2CF74Q33436416-00B92E1E-3AD5-4143-9BE2-DF5BD9BDF164Q33436425-2A3DA52E-3815-4EB3-A14A-3810CBEBCF25Q33458169-96C4B17B-5227-4FB7-AC2F-F7B2221E71ADQ34434805-77DD6BD9-8AD1-4141-A8DB-ECFF468E3E41Q36441428-273E379B-FF9F-4C11-8B72-8F9B59627478Q36798554-2A0D326D-CE1C-454A-9F90-A63197A9C259Q37417311-00C12B78-7D72-47D4-AF2F-D6F30319F615Q38073018-EB52E481-B4D4-4A96-AF0A-4587ECD1382AQ38832223-C9FE1D19-1940-4E42-9196-C3943E30A446Q40307437-B6C47C54-397B-4F66-B885-C36CF1B68E98
P2860
The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study.
description
1974 nî lūn-bûn
@nan
1974 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
The prophylactic treatment of ...... atelets: a double blind study.
@ast
The prophylactic treatment of ...... atelets: a double blind study.
@en
type
label
The prophylactic treatment of ...... atelets: a double blind study.
@ast
The prophylactic treatment of ...... atelets: a double blind study.
@en
prefLabel
The prophylactic treatment of ...... atelets: a double blind study.
@ast
The prophylactic treatment of ...... atelets: a double blind study.
@en
P2093
P1433
P1476
The prophylactic treatment of ...... atelets: a double blind study.
@en
P2093
P2860
P304
P356
10.1111/J.1537-2995.1974.TB04558.X
P577
1974-09-01T00:00:00Z